In this study of type 2 diabetes, we propose that n-3 PUFA-mediated ASM downregulation improves diabetic retinopathy outcomes through inhibition of retinal vascular damage and enhanced EPC function leading to retinal vascular repair. Here, SMPD1 is linked to type 2 diabetes mellitus.